Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-02
1988-09-27
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
047742500
ABSTRACT:
There are described an anti-cancer composition and a method of treating differentiated carcinomas or melanoma, Featuring a suitable carrier and particular 2,4,6-tri(aryl or heteroaryl) thiapyrylium dyes.
REFERENCES:
patent: 3250615 (1966-05-01), Van Allan et al.
patent: 3615418 (1969-06-01), Standenmayer et al.
patent: 3679408 (1972-07-01), Keyman et al.
patent: 4125414 (1978-11-01), Tang et al.
patent: 4341894 (1982-07-01), Regan et al.
Khim-Farm., ZH., vol. 15, No. 11 pp. 38-40 (1981).
Arnold Lockshin et al., "Effectiveness of Anticancer Drugs Determined in Nude Mice Inoculated with [1251]-Iodo-2'-Deoxyuridine-Prelabeled Human Melanoma Cells", JNCI, vol. 74, No. 4, Apr. 1985, pp. 899-903.
Beppino C. Gioranella, PHD et al., "Correlation Between Response to Chemotherapy of Human Tumors in Patients and in Nude Mice"; Cancer, Oct. 1, 1983, pp. 1146-1152.
Chen Lan Bo
Humphlett Wilbert J.
Dana Farber Cancer Institute
Goldberg Jerome D.
Schmidt Dana M.
LandOfFree
Composition and method for treating differentiated carcinoma or does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treating differentiated carcinoma or , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treating differentiated carcinoma or will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398148